General
Preferred name
NIFEDIPINE
Synonyms
Nifedipine D6 ()
BAY-a-1040 D6 ()
BAY-a-1040 ()
Procardia ()
Adalat ()
Procardia XL ()
nifedipine once daily, Watson ()
Nifedipine (BAY-a-1040) ()
Nifedipress MR 10 ()
BAY A 1040 ()
Calchan MR 10 ()
Calchan MR 20 ()
Neozipine XL ()
NSC-757242 ()
Adalat A.R. ()
Nifopress MR ()
Slofedipine XL 60 ()
Genalat 20 Ret ()
Adipine MR 20 ()
Valni XL ()
Vasad ()
Afeditab Cr ()
Hypolar XL 30 ()
Adipine MR 10 ()
Unipine XL ()
Adalat LA 20 ()
Angiopine MR 10 ()
Nimodrel XL ()
Nifedipress MR 20 ()
Valni 20 Ret ()
Angiopine 40 LA ()
Nimodrel MR 20 ()
Hypolar Ret 20 ()
Hypolar Ret 10 ()
Adalat Ret ()
Fortipine LA40 ()
Tensipine MR 20 ()
Calcilat ()
Kentipine MR 10 ()
Nife-Wolff ()
Nivaten Ret ()
Adalate LP ()
Nifensar Xl ()
Nifedipine hydrochloride ()
Adalat Cc ()
Kentipine MR 20 ()
Nifelease ()
Nifedipinum ()
Coracten SR ()
Adanif XL ()
Calanif ()
Nifopress Ret ()
Nifedipine slow release ()
Angiopine MR 20 ()
Adalat LA 30 ()
Nimodrel MR 10 ()
Coracten XL ()
Adalat IC ()
Coracten ()
Slofedipine XL 30 ()
Kentipine ()
Angiopine 5 ()
Adipine XL ()
Coroday MR ()
Cardilate MR ()
Tensipine MR 10 ()
Adalat LA 60 ()
Angiopine 10 ()
Genalat 10 Ret ()
Nifedotard 20 MR ()
Nifedipine-d6 ()
P&D ID
PD001839
CAS
21829-25-4
101539-70-2
1188266-14-9
Tags
available
drug
Approved by
FDA
First approval
1981
Drug Status
approved
withdrawn
Drug indication
Vasodilator (coronary)
Angina pectoris
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION One of the dihydropyridine class of drugs. (GtoPdb)
DESCRIPTION L-type Ca2+ channel blocker; vasodilator (LOPAC library)
DESCRIPTION Potent and selective GluK1 kainate agonist (Tocris Bioactive Compound Library)
DESCRIPTION Ca2+ channel blocker (L-type) (Tocriscreen Total)
Cell lines
5
Organisms
7
Compound Sets
37
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
Ki Database
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Tocriscreen Total
Withdrawn 2.0
ZINC Tool Compounds
External IDs
56
Properties
(calculated by RDKit )
Molecular Weight
346.12
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
1
Rotatable Bonds
4
Ring Count
2
Aromatic Ring Count
1
cLogP
2.18
TPSA
107.77
Fraction CSP3
0.29
Chiral centers
0.0
Largest ring
6.0
QED
0.51
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
L-type
Target
Calcium Channel
CAM
Potassium Channel
CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNB2, CALM1, GLRA1, GLRA3, GLRB, KCNA1, KCNA5, NR1I2, TRPM3
Ca channel blocker
Pathway
Membrane Transporter/Ion Channel
Neuronal Signaling
Neuroscience
Autophagy
Primary Target
CaV1.x Channels (L-type)
MOA
Blocker
Calcium Channel Blockers
Antioxidants
"Calcium Channel Blockers
Antioxidants"
calcium channel blocker
Member status
member
Indication
vasospastic angina, chronic stable angina
ATC
C08CA05
Toxicity type
cardiovascular
Therapeutic Class
Analgesics
Source data